ReviewJournal of ginseng research2026
Ginsenosides Rh2 and Rg3 in first-line combination therapy: Prospects for rapid clinical translation in drug-resistant triple-negative breast cancer.
Sungpil Yoon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.